Deutsche Bank initiates coverage of Achillion (ACHN +12.35% to $9.10) with a "Buy" and gives the...

|About: Achillion Pharmaceuticals... (ACHN)|By:, SA News Editor

Deutsche Bank initiates coverage of Achillion (ACHN +12.35% to $9.10) with a "Buy" and gives the company a price target of $12, saying it's unpartnered and under-appreciated. Deutsche Bank is confident about Achillion's hepatitus C drugs, and said it could be a takeover target. Meanwhile, BofA upgrades Achillion to a "Buy" from "Underperform."